The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
As the baby boomer generation has begun to reach retirement age, the need for specialized knowledge on geriatric psychopharmacology has grown. Clinical Manual of Geriatric Psychopharmacology, Second Edition, serves a vital need for an expanding patient population, offering specialized information not available elsewhere in a standardized, well-organized format that clinicians will find easy to use. Extensively updated from the first edition to reflect the large body of new literature, this edition covers all newly available drugs, new safety warnings, information about adverse effects, and efficacy for expanded or more limited indications. Information is presented as concise bulleted text, and key concepts are highlighted in boxes. This edition is compatible with the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5®).
Understanding the complex pharmacological changes that occur with aging is critical for psychiatrists, psychiatric residents, and all health professionals who prescribe and/or monitor medications for geriatric patients. Clinical Manual of Geriatric Psychopharmacology, Second Edition, is comprehensive, current, and serves a critical need for the busy clinician.